SERM : Raloxifene Flashcards
Antiresorptive Agents - slow rate bone loss
1
Q
Raloxifene
MOA
A
Modifies gene expression by binding to the nuclear oestrogen receptors differentially in tissue, to turn on/off transcription
2
Q
Raloxifene
Abs/Distrb/Elim
A
Given orally, undergoes first-pass metabolism. Bioavailabity ~ 2%.
Plasma half life ~ 32h
3
Q
Raloxifene
Clinical use
A
Indicated alternative to bisphosphonate prevention for osteoporosis in postmenopausal women at risk of breast cancer
4
Q
Raloxifene
Adverse effects
A
Increased risk of venous thromboembolism
(reduced risk of breast cancer and no risk of endometrial or ovarian cancer comparted to HRT)